South Korea Pericarditis Market Summary
The South Korea Pericarditis market is projected to experience substantial growth from 74.8 USD Million in 2024 to 195 USD Million by 2035.
Key Market Trends & Highlights
South Korea Pericarditis Key Trends and Highlights
- The market is expected to grow at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 195 USD Million, reflecting a robust increase in demand.
- In 2024, the market is valued at 74.8 USD Million, indicating a strong foundation for future growth.
- Growing adoption of advanced diagnostic techniques due to increasing awareness of pericarditis is a major market driver.
Market Size & Forecast
2024 Market Size | 74.8 (USD Million) |
2035 Market Size | 195 (USD Million) |
CAGR (2025-2035) | 9.1% |
Major Players
Yuhan Corporation, Celltrion, GC Pharma, Medytox, Hanmi Pharmaceutical, SK Biopharmaceuticals, Korea United Pharm, SillaJen, Korean Pharmaceutical Association, LG Chem, Hugel, Daewoong Pharmaceutical, Genexine, NMCS, Samsung Biologics